US FDA's Orphan Drug Designation Reviews Often Don't Include Regulatory Histories, GAO Says

FDA entrance sign 2016
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Rare Diseases

More from Pink Sheet